HHoMu Health Ventures
HoMu Health Ventures is a Barcelona-based incubator, accelerator and venture builder for biomedicine start-ups, with a focus on reproductive and women's health. It backs and builds early-stage companies in reproductive medicine, genomics, medical devices, drug discovery, AI, diagnostics and telemedicine, investing at pre-seed and seed and providing scientific advice, investor sourcing, partnership support and operational help. Its portfolio includes Sama, EmbryoCloud, GenEmbryomics, Ovum Health, Butterfly and Rosa Scientific, and its founders' previous ventures Reprogenetics and Recombine were acquired. It was founded in 2019 by reproductive-health scientists Santiago Munné, José Horcajadas and David Cotán together with businessman Delfí Torns, has laboratories in Seville, and in 2021 expanded its capital to around €1 million with backing from business angels and healthcare executives.
Profile updated 24 Sep 2026
Founders
Global models
Investors
Funding rounds 1
News & media 4
| Published | Article |
|---|---|
| 2026-02-18 |
Genomic Prediction Appoints Santiago Munné, Ph.D., as Chief Scientific Officer ↗
BioSpace (press release)
|
| 2024-06-12 |
Synergyne ART Analytics Inc. and HoMu Health Ventures Forge a Strategic Partnership to Revolutionize Fertility Tech ↗
EIN Presswire
|
| 2024-03-10 |
217 A Cold VC Climate, an IVF Start Up Incubator, and 15 new fertility companies with Dr. Santiago Munné ↗
Fertility Bridge (Inside Reproductive Health)
|
| 2024-01-19 |
Arediana cierra su primera ronda de financiación por 300.000 euros ↗
MuyPymes
|